Promote and fund research into developing better diagnostic processes, therapies, and cures for frontotemporal degeneration (FTD); provide information, education, support and advocacy to persons diagnosed with FTD, their families and caregivers; educate physicians and other health professionals about FTD and how to improve patient care; bring about greater public awareness of the nature and prevalence of frontotemporal degeneration and the needs of those who are coping with it; advocate with public officials and promote public and private programs that provide appropriate, affordable and high-quality long-term health care and social services.
This 501(c)(3) elected the 501(h) safe-harbor — lobbying expenditures are capped under a clear dollar formula instead of the "insubstantial part" standard.